Clearlake Capital Makes Majority Growth Investment in ModMed
March 3, 2025
Clearlake Capital Group has completed a significant majority growth investment in ModMed, a specialty-specific healthcare SaaS platform with AI-powered medical practice technology. Financial terms were not disclosed. The deal follows Clearlake’s acquisition of ModMed from Warburg Pincus (per initial announcement) and aims to accelerate ModMed’s AI and growth roadmap.
- Targets
- ModMed
- Sellers
- Warburg Pincus
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ModMed Acquires Bonsai Health
April 20, 2026
Healthcare Services
ModMed, backed by Clearlake Capital, announced it has acquired Bonsai Health, a high-growth agentic AI patient engagement platform. The deal adds front-office automation such as automated patient reactivation and AI-driven self-scheduling into ModMed’s AI-Powered Practice for specialty medical practices.
-
Clearlake Leads Strategic Investment in Aptean
July 1, 2024
Cloud & SaaS
Aptean, a provider of industry-specific ERP and supply chain software headquartered in Alpharetta, Georgia, received a strategic investment led by Clearlake Capital Group. Clearlake joins existing investors TA Associates, Insight Partners, and Charlesbank Capital Partners to support Aptean's product innovation, cloud/SaaS expansion, and global growth ambitions.
-
Clearlake Capital Completes Acquisition of Quest Software from Francisco Partners
February 2, 2022
Cybersecurity
Clearlake Capital Group completed its acquisition of Quest Software from Francisco Partners, making Clearlake the majority shareholder and partnering with Quest’s existing management team to pursue a buy-and-build strategy. The investment aims to accelerate Quest’s cloud/SaaS adoption, expand its identity-centric cybersecurity, data intelligence, and IT operations management offerings, and drive growth organically and through M&A.
-
TEAM Technologies (Clearlake-backed) Acquires iiMED Medical Solutions from ACON Investments
January 12, 2022
Medical Devices
TEAM Technologies, a Clearlake Capital-backed specialty manufacturer, has acquired iiMED Medical Solutions from ACON Investments. iiMED is a nearshore manufacturer of FDA Class I & II consumable medical devices based in Amherst, New York with manufacturing in Reynosa, Mexico; the deal expands TEAM's medical device manufacturing capabilities and nearshore footprint. Financial terms were not disclosed.
-
Motive Partners & Clearlake Acquire Majority Stake in InvestCloud
February 2, 2021
Cloud & SaaS
Funds advised by Motive Partners and Clearlake Capital acquired an 80% stake in InvestCloud and combined it with Motive portfolio companies Finantix and Tegra118 to create a global, next-generation SaaS wealth solutions platform. Co-investors in the transaction included Accenture, Citi Ventures and Fiserv; the combined InvestCloud Group will target global wealth managers, private banks and asset managers with an integrated cloud-native offering.
-
Clearlake Capital Acquires Provation Medical from Wolters Kluwer
March 12, 2018
Software
Clearlake Capital Group has acquired Provation Medical from Wolters Kluwer, making Provation a newly independent software platform to accelerate growth. Provation is a leading provider of procedure documentation, coding, and clinical decision-support software used by hospitals and ambulatory surgery centers; Clearlake intends to support product investment and pursue a buy-and-build growth strategy.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.